The following studies suggest that the Third Eye Retroscope may benefit you and your patients. Avantis supported research has been presented at various U.S. and international gastroenterological society meetings. Click a reference to view the full abstract.
Effect of a Retrograde-Viewing Device on Adenoma Detection Rate during Colonoscopy: The “TERRACE” Study
Leufkens AM, DeMarco DC, Siersema PD, et al. Effect of a Retrograde-Viewing Device on Adenoma Detection Rate during Colonoscopy: The “TERRACE” Study. Gastrointest Endosc 2011;73:480-9.
Abstract and full article (Note: You will be prompted to log-in or register to view the full article)
Impact of Experience with a Retrograde-Viewing Device on Adenoma Detection Rates and Withdrawal Times during Colonoscopy: the Third Eye Retroscope Study Group
DeMarco DC, Odstrcil E, Lara LF, et al. Impact of Experience with a Retrograde-Viewing Device on Adenoma Detection Rates and Withdrawal Times during Colonoscopy: the Third Eye Retroscope Study Group. Gastrointest Endosc 2010;71:542-50.
Full Article
A Retrograde-Viewing Device Improves Detection of Adenomas in the Colon: A Prospective Efficacy Evaluation
Waye JD, Heigh RI, Rex DK, et al. A Retrograde-Viewing Device Improves Detection of Adenomas in the Colon: A Prospective Efficacy Evaluation. Gastrointest Endosc 2010;71:551-6.
Full Article
A related study, not funded by Avantis Medical Systems, evaluates CT Colonography and retrograde viewing:
A number of related studies have been published in peer-reviewed journals. The following three studies are frequently cited in other articles as demonstrating that current colonoscopy technology is limited in its accuracy and sensitivity, resulting in unacceptable miss rates for colorectal cancers and pre-cancerous adenomas:
Two studies confirmed the significance of high miss rates in colonoscopy and generated additional interest in the issue among endoscopists and patients:
The Third Eye® Retroscope® has not yet been cleared by FDA for a specific detection rate.
MKT 16044, Rev B